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Hypoxemia and Arrhythmia during Daily Activities and  
Six-minute Walk Test in Fibrotic Interstitial Lung Diseases
We performed 24-hr monitoring of pulse oximetric saturation (SpO2) with ECG and six-
minute walk test (6MWT) in 19 patients with fibrotic interstitial lung diseases (ILD) to 
investigate; 1) The frequency and severity of hypoxemia and dysrhythmia during daily 
activities and 6MWT, 2) safety of 6MWT, and 3) the parameters of 6MWT which can 
replace 24-hr continuous monitoring of SpO2 to predict hypoxemia during daily activities. 
All patients experienced waking hour hypoxemia, and eight of nineteen patients spent  
> 10% of waking hours in hypoxemic state. Most patients experienced frequent 
arrhythmia, mostly atrial premature contractions (APCs) and ventricular premature 
contractions (VPCs). There were significant correlation between the variables of 6MWT and 
hypoxemia during daily activities. All of the patients who desaturated below 80% before 
300 meters spent more than 10% of waking hour in hypoxemia (P = 0.018). In contrast to 
waking hour hypoxemia, SpO2 did not drop significantly during sleep except in the patients 
whose daytime resting SpO2 was already low.  In conclusion, patients with fibrotic ILD 
showed significant period of hypoxemia during daily activities and frequent VPCs and 
APCs. Six-minute walk test is a useful surrogate marker of waking hour hypoxemia and 
seems to be safe without continuous monitoring of SpO2.
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ORIGINAL ARTICLE
Respiratory Diseases
INTRODUCTION
Exercise induced hypoxemia is a characteristic feature of inter-
stitial lung diseases (ILD) and clinically, it is frequently seen dur-
ing six-minute walk test (6MWT). Although they are not hypox-
emic at rest, oxygen saturation tends to drop abruptly shortly 
after starting to walk and the recovery is very slow. The patients 
may experience more severe and longer desaturation during 
daily activities than 6MWT because 6MWT is submaximal ex-
ercise test. Cardiac arrhythmia frequently occurred in the pa-
tients with chronic obstructive pulmonary disease (COPD) and 
sleep apnea (1-4) and hypoxemia is one of the main causes of 
arrhythmia in these patients (5). Therefore we can assume that 
the patients with ILD may have more arrhythmia, because they 
have more severe exercise induced hypoxemia than those with 
COPD or sleep apnea. 
  However, there were few reports that evaluate the frequency 
and severity of hypoxemia and arrhythmia during 6MWT and 
daily activities in the patients with ILD. The recently published 
American Thoracic Society (ATS) guideline on 6MWT states that 
there is no need to monitor pulse oximetric saturation (SpO2) 
continuously during the test and recommends to stop the test 
only when the patients complain symptoms of respiratory or 
circulatory distress. And during the test, oxygen should be de-
livered in the same way with the same flow as usual use.
  Therefore, the aims of this study are to investigate; 1) The fre-
quency and severity of hypoxemia and dysrhythmia during dai-
ly activities and 6MWT, 2) safety of 6MWT, and 3) the parame-
ters of 6MWT which can replace 24-hr continuous monitoring 
of SpO2 to predict hypoxemia during daily activities. 
  For these purposes, we performed 24-hr continuous moni-
toring of Holter ambulatory ECG and SpO2 on the patients with 
ILD who demonstrated exercise induced hypoxemia.
MATERIALS AND METHODS
Subjects
Subjects were recruited from ILD outpatient clinic of Asan Med-
ical Center, Seoul, Korea. Nineteen patients (male:female = 9:10) 
agreed to participate in this study. Diagnosis was made accord-Park JH, et al.  •  Hypoxemia and Arrhythmia in Pulmonary Fibrosis
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ing to ATS/European Respiratory Sociery (ERS) Classification 
of the idiopatic interstitial pneumonia (IIP) (6) and criteria for 
specific collagen vascular disease (CVD) (7-9). Hypoxemia was 
defined as SpO2 less than 88%. None of them showed resting 
hypoxemia and right heart failure on transthoracic echocar-
diography. 
 
24-hr monitoring of pulse oximetric saturation (SpO2) and 
ECG by Holter 
SpO2 and heart rates were also monitored for 24-hr using Nell-
cor N-595 (Bemes, Inc., CA, USA) or Nonin 3100 WristOx (Nonin 
Medical, Inc., Plymouth, MN, USA). The ECG rhythm was con-
tinuously recorded with Holter monitor (SEER MC ambulatory 
monitor, GE Marquette, Milwaukee, WI, USA) simultaneously. 
The pulse oximeters had memory cards with 24-hr storage ca-
pacity. While being monitored, patients recorded detailed diary 
including activities, any symptoms or events. The results were 
analyzed separately for waking hours and sleeping hours. Data 
were analyzed with PROFOX oximetry software (PROFOX as-
sociates, Inc., Escondido, CA, USA).
Six-minute walk test 
The 6MWT was performed according to modified ATS guide-
line by the same trained person (10). The test was done at the 
long hospital corridor and the examiner followed behind the 
patients without any encouragement. SpO2 and heart rates were 
monitored continuously during the test with a pulse oximetry 
(N20 PA, Nonin Medical instruments) and the measurements 
were automatically printed out every 30 sec. 
Pulmonary Function Test (PFT)
Spirometry (Vmax22; Sensormedics Yorba Linda, CA, USA), ple-
thysmographic lung volumes (6200 Plethysmograph; Sensor-
medics) and diffusing capacity (DLCO) (Vmax229D; Sensormed-
ics) were measured. 
High-Resolution CT Scanning (HRCT)
HRCT scan were reviewed by one thoracic radiologists who was 
blinded to clinical and histologic diagnosis. The extent of retic-
ular opacity and honeycombing were scored on a scale of 5% 
for all lobes. And the mean values of all 6 lobes (lingular division 
was treated as independent lobe) were regard as the extent of 
abnormalities. Fibrotic score was the sum of the extent of retic-
ular opacity and honeycombing. 
Statistical analysis 
All values were expressed as mean ± standard deviation except 
the duration of SpO2 less than 88%, which was presented as me-
dian value. Categorical data were compared using Fisher’s ex-
act test. A Spearman correlation coefficient was used to exam-
ine the association between SpO2, 6MWT, and pulmonary func-
tion test. P < 0.05 was considered as statistically significant (two-
tailed). All data were analyzed using SPSS 12.0 version.
Ethics statement
This study was approved by the institutional review board of the 
Asan Medical Center (IRB approval number: 2006-0303). All 
subjects submitted written informed consent.
RESULTS
Patients’ characteristics
Table 1 shows the demographic features of the patients. Three 
patients had collagen vascular disease; one with undifferentiat-
ed connective tissue disease with nonspecific interstitial pneu-
monia pattern pathology, one with systemic sclerosis with usu-
al interstitial pneumonia pattern pathology. The last patient had 
mixed connective tissue disease and extensive honeycombing 
on HRCT. 
  There was no current smoker, 9 of them are nonsmokers and 
the remainders are exsmokers. And there was no statistically sig-
nificant difference in results of PFT, SpO2 monitoring and 6MWT 
between nonsmokers and exsmokers (data were not shown).
Pulse oximetric saturation monitoring (SpO2)
Table 2 shows the individual data of 24-hr SpO2 and 6MWT. No 
patient showed resting hypoxemia. However, all patients desat-
urated during waking hours. The minimum SpO2 during wak-
ing hours was between 80%-89% in five patients, 70%-79% in 
10, and below 70% in the remaining four patients. The duration 
of hypoxemia during waking hours was variable from 0.3% to 
46.7% depending on not only the severity of the disease but also 
how active the patients were. Eight of nineteen patients spent 
more than 10% of waking hours in hypoxemic state.
  In contrast to severe hypoxemia during waking hours, only 3 
Table 1. Clinical characteristics of the patients
Characteristics Values
Age (yr)   58 ± 11
Male:Female 9:10
BMI (kg/m
2)   23.7 ± 3.10
Diagnosis
   Idiopathic pulmonary fibrosis
   Nonspecific interstitial pneumonia
   CVD-IP
 
13 (SLBx:8)
  3 (SLBx:3)
  3 (SLBx:2)
Pulmonary function test
   FVC % predicted
   FEV1/FVC
   DLCO %predicted
   DL/VA %predicted
   TLC %predicted
 
  55.6 ± 16.4
86.4 ± 7.7
  40.8 ± 12.5
  74.1 ± 24.4
  59.6 ± 13.2
CVD-IP, collagen vascular disease associated with interstitial pneumonia; SLBx, sur- 
gical lung biopsy; BMI, body mass index; FVC, forced vital capacity; FEV1, fored 
expiratory volume in one second; DLco, diffusion capacity of corbon monoxide; VA, 
alveolar volume; TLC, total lung capacity.Park JH, et al.  •  Hypoxemia and Arrhythmia in Pulmonary Fibrosis
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patients desaturated during sleeping hours (Table 2). In one pa-
tient (case 13), the minimal saturation during sleep was 87% and 
the duration of hypoxemia was only 0.9% of the sleeping hours. 
The other two patients (case 18 and case 19) were hypoxemic for 
more than 70% of their sleeping hours; however, during waking 
hours, their oxygen saturation was marginal even at rest (SpO2 
at complete rest was 92%, 91%, respectively), therefore only slight 
drop of SpO2 resulted in hypoxemic state. In all other 16 pati-
ents, the mean sleeping SpO2 was almost the same or higher 
than the mean waking SpO2. 
Six-minute walk test
The mean distance walked during 6MWT was 416.2 ± 100.0 m. 
The saturation dropped down to lower than 90% in all patients 
(Table 2). The minimum saturation during 6MWT was 80% or 
over in eight patients, 70%-79% in six and less than 70% in five 
patients. In most patients, the saturation dropped down very 
rapidly after starting to walk (in eleven patients it reduced to less 
than 80% within 3 min).
ECG monitoring
Table 3 shows the results of 24-hr ECG monitoring of individual 
patients. Many patients had variable numbers of atrial prema-
ture contractions (APCs) or ventricular premature contractions 
(VPCs). The frequency of these rhythm disturbances was not 
different during sleep hour from waking hour. In addition, eight 
patients showed other noticeable arrhythmias including bigem-
inal cycles during walking at 60% and 80% of SpO2 in two pati-
ents. However, these episodes of arrhythmia occurred in both 
hypoxemic and normoxemic condition and all of these arrhyth-
mia were completely asymptomatic. One patient (case 16) show-
ed atrial flutter with variable conduction for all the time and the 
rhythm did not change during exercise or hypoxemic periods. 
  During 6MWT, atrial tachycardia occurred at 66% of SpO2 in 
one patient (case 13); however, she was asymptomatic at that 
time. Not only during 6MWT, but also during waking hours she 
experienced a lot of short runs of APCs, atrial tachycardia and 
second degree AV block at both low and high SpO2. No clinical-
ly significant arrhythmia that needs to be treated was induced 
by hypoxemia during daily activities and 6MWT. 
The relationship between physiologic, radiologic 
parameters and waking hour hypoxemia
Correlation between 6MWT, HRCT findings, PFT and 24-hr 
SpO2 is shown in Table 4. Total distance was significantly corre-
lated with duration of hypoxemia during waking hours and 24-
hr mean SpO2. The distance walked until SpO2 reduced to 80% 
during 6MWT showed positive correlation with the lowest SpO2 
and 24-hr mean saturation and negative correlation with dura-
tion of hypoxemia (Fig. 1). In HRCT findings, fibrotic score show-
ed positive correlation with the duration of hypoxemia and hon-
eycombing showed negative correlation with 24-hr mean satu-
ration. In PFT, diffusing capacity showed positive correlation 
with lowest SpO2 and 24-hr mean saturation and negative cor-
relation with duration of hypoxemia. And the patients who de-
saturated below 80% before 300 meters during 6MWT spent 
Table 2. The results of saturation monitoring in individual patients
Case
No.
Age (yr)/ 
Sex 
Dx
Resting  
SpO2
24 hr  
mean SpO2
Waking Sleeping 6MWT
Min. % Min. % Dista-nce
† Min. SpO2
Time to 
80%
‡
  1 45/F NSIP 97 97.0 87 0.4 93 0 621 66 2.0
  2 68/M IPF* 95 94.0 85 4.0 92 0 477 82 -
  3 63/F IPF 96 96.0 84 0.3 94 0 496 89 -
  4 78/M IPF* 95 93.5 82 10.9 93 0 334 80 3.3
  5 66/F NSIP 96 96.0 82 1.1 93 0 358 79 5.3
  6 65/M IPF 93 90.6 78 17.8 90 0 195 80 6.0
  7 78/F IPF* 94 96.1 76 0.6 94 0 380 82 -
  8 54/M IPF* 96 95.0 76 2.9 92 0 572 73 2.7
  9 70/M IPF 94 91.7 75 9.7 90 0 417 76 2.3
10 51/F IPF 95 91.0 75 15.5 90 0 363 71 2.7
11 54/F IPF 96 94.2 72 10.8 93 0 487 75 2.5
12 49/F CVD 98 96.0 72 4.8 92 0 467 66 2.5
13 58/F NSIP 94 91.5 72 20.2 87 0.9 355 66 1.7
14 49/F CVD 96 91.7 71 9.3 91 0 434 83 -
15 47/M IPF 97 93.1 70 4.9 90 0 284 80 2.0
16 44/M CVD* 97 97.8 68 3.8 90 0 450 80 6.0
17 52/M IPF 96 93.5 65 12.7 92 0 450 74 1.8
18 71/M IPF* 91 87.0 64 46.7 80 77.9 444 67 1.5
19 47/F IPF 92 87.0 60 41.6 82 71.8 324 60 1.7
*diagnosis without surgical lung biopsy; 
†meters; 
‡minutes. Dx, diagnosis; Min, minimum saturation; %, duration (%) of less than 88% of SpO2; IPF, idiopathic pulmonary 
fibrosis; CVD, interstitial pneumonia associated with collagen vascular disease; NSIP, nonspecific interstitial pneumonia; SpO2, pulse oximetric saturation; 6MWT, six-minute 
walk test. Park JH, et al.  •  Hypoxemia and Arrhythmia in Pulmonary Fibrosis
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Table 3. The results of 24-hr ECG monitoring of individual patients
Case 
No.
Age (yr)/ 
Sex 
Diagnosis
The findings of Holter monitoring
Atrial premature complex Ventricular premature complex
Isolated Couplet Runs Isolated Couplet Runs
  1
  2
  3
45/F
68/M
63/F
NSIP
IPF*
IPF
7
42
121
0
7
157
0
0
1(3)
6
5
6
0
0
0
0
0
0
One episode of atrial tachycardia-sleeping, SpO2 96%
  4 78/M IPF* 375 8 9 (8) 916 5 0
Longest short runs of APCs-walking, SpO2 88%
  5
  6
  7
  8
66/F
65/M
78/F
54/M
NSIP
IPF
IPF*
IPF*
59
0
54
26
5
0
5
0
0
0
0
0
2
0
0
12
0
0
0
0
0
0
0
0
One episode of atrial tachycardia (walking, SpO2 86%)
  9 70/M IPF 10 3 1 (4) 6 0 0
A short run of APCs (walking, SpO2 85%)
10
11
12
13
51/F
54/F
49/F
58/F
IPF*
IPF
CVD
NSIP
1113
229
53
6,245
0
139
11
1,835
0
0
0
1,584 (11)
6
0
4
2,374
0
0
0
39
0
0
0
1 (3)
Longest runs of APCs-11 beats, 6MWT, SpO2 66%, a short run of VPCs-resting, SpO2 93%, One run of bigeminy (113 cycles)-walking, SpO2 80%, 
2 sec-degree AV blocks-sleeping, a Mobitz type I-SpO2 90%, a Mobitz type II-SpO2 94%
14 49/F CVD 31 2 1 (3) 3 0 0
A short run of APCs (resting, SpO2 96%)
15
16
47/M
44/M
IPF
CVD*
0
0
0
0
0
0
20
20
0
0
0
0
Atrial flutter with variable conduction (all the time of monitoring)
17
18
19
52/M
71/M
47/F
IPF
IPF*
IPF
0
13
13
0
0
0
0
0
0
0
1
74
0
0
0
0
0
0
A short run of bigeminy (17 cycles)-walking, SpO2 60%
The number in parenthesis: the number of beats of the longest run. *diagnosis without surgical lung biopsy. IPF, idiopathic pulmonary fibrosis; CVD, interstitial pneumonia associated 
with collagen vascular disease; NSIP, nonspecific interstitial pneumonia; APC, atrial premature complex; VPC, ventricular premature complex; 6MWT, six-minute walk test.
more than 10% of waking hours in hypoxemic state (Table 5). 
These results suggested that the parameters of 6MWT can re-
flect the waking hour oxygen saturation and replace the 24-hr 
SpO2 monitoring.
DISCUSSION
In this study, we found that patients with fibrotic interstitial 
pneumonia experienced significant hypoxemia during waking 
hours whereas significant oxygen desaturation during sleep was 
Table 4. Correlation between physiologic, radiologic parameters and pulse oximetric 
saturation
Parameters
Minimum  
SpO2 (%)
Log10duration 
of SpO2 
< 88% (%)  
during waking 
24-hr mean 
SpO2 (%)
Six-minute walk test
   Total distance (meters)
   Walk distance until 80% of SpO2
‡
   Time taken until 80% of SpO2
§
   Minimum SpO2 (%)
 
r = 0.254
r = 0.604*
r = 0.556*
r = 0.340
 
r = -0.544*
r = -0.801
†
r = -0.454
r =-0.440
 
r = 0.657
†
r = 0.799
†
r = 0.444
r = 0.185
HRCT findings
   Reticular opacity
   Honeycombing
   Fibrotic score
 
r = -0.059
r = -0.129
r = 0.000
 
r = 0.176
r = 0.454
r = 0.510*
 
r = -0.059
r = -0.476*
r = 0.000
Pulmonary function test
   FVC %predicted
   TLC %predicted
   DLCO %predicted
 
r = 0.524*
r = 0.457*
r = 0.513*
 
r = -0.409
r = -0.183
r = -0.729
†
 
r = 0.196
r = 0.097
r = 0.728
†
*P < 0.05; 
†P < 0.01; 
‡meters; 
§minutes. SpO2, pulse oximetric saturation; HRCT, high 
resolution computerized tomography. 
Fig. 1. The relationship of six-minute walk test and duration of waking hour hypoxemia. 
There was significant negative correlation between walk distance until 80% of SpO2 
during six-minute walk test and the duration of hypoxemia during daily activities in 
patients with interstitial lung diseases.
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not seen except only two patients who showed marginal resting 
SpO2. And they also experienced frequent cardiac arrhythmia 
although most of them were APCs and VPCs, asymptomatic and 
not specifically correlated with hypoxemia. Many parameters 
of 6MWT were correlated with the degree and duration of de-
saturation during waking hours and can, therefore, be utilized 
as a surrogate marker of hypoxemia during waking hours. Al-
though the SpO2 dropped significantly, clinically significant ar-
rhythmia was not observed during 6MWT. 
  Many patients with advanced ILD become severely desatu-
rated immediately after starting exercise although they were not 
hypoxemic at rest. Therefore, many of them were suspected to 
spend significant time in hypoxemic state. In our study, we found 
that the oxygen saturation became very low even with usual dai-
ly activities in some patients. Two patients in this study spent 
almost half of waking hours in hypoxemic state. 
  Although the benefit of oxygen supplementation in patients 
with ILD was not well studied, there were many evidences that 
supplemental oxygen improves survival and exercise tolerance 
of hypoxemic COPD patients (11, 12). Therefore, these patients 
may have benefit via supplemental oxygen therapy and it may 
be valuable to identify the patients who spend significant hypox-
emic period during their daily activities.
  It is impossible to perform 24-hr SpO2 monitoring for all pa-
tients with ILD. So, simple method which can predict desatura-
tion during daily activities is required. The 6MWT is a simple 
and widely-used stress test to evaluate the functional status of 
patients with chronic lung diseases (13-16). In our study, vari-
ables of 6MWT were well correlated with 24-hr SpO2 monitor-
ing results. Thus, data from 6MWT, especially desaturation be-
low 80% before 300 meters can be used as a surrogate for signif-
icant waking hour ambulatory hypoxemia and an indicator of 
oxygen supplementation regardless of resting SpO2.
  There are some concerns about the safety of 6MWT in ILD 
patients. These patients experienced severe hypoxemia during 
6MWT. Therefore, there is a risk for developing life threatening 
arrhythmia during 6MWT. Because of the paucity of the study 
on Holter monitoring during 6MWT (14) and early termination 
of 6MWT before severe hypoxemia in most studies (15, 16), the 
safety of 6MWT during severe desaturation (SaO2 ≤ 80%) is not 
known. 
  Fortunately, significant cardiac arrhythmia was rarely oc-
curred during maximal exercise test or sleep in the patients with 
COPD and ILD despite severe hypoxemia (1, 17, 18). We can 
assume that the frequency of significant cardiac arrhythmia in 
6MWT is much less if it occurs, than that of maximal exercise 
tests because 6MWT is self-paced submaximal exercise test. We 
monitored ambulatory ECG during 6MWT to evaluate the safety 
of 6MWT. No clinically significant arrhythmia occurred although 
many patients experienced hypoxemia below 80%. We could 
conclude that 6MWT was a safe test even for the patients with 
ILD who showed exercise induced hypoxemia. 
  There were only a few reports about arrhythmia in ILD pati-
ents, whereas there were many reports about cardiac arrhyth-
mia in patients with COPD and obstructive sleep apnea (OSA) 
(2, 3). The common arrhythmias include atrial tachycardia, non-
sustained ventricular tachycardia, sinus arrest, second-degree 
atrioventricular conduction block, and frequent VPCs (1, 19, 20). 
As we expected, ILD patients also experienced a lot of arrhyth-
mia during daily activities. The most frequent arrhythmias were 
APCs, VPCs with several episodes of noticeable dysrhythmia 
such as bigeminy, atrial tachycardia, or flutter in some patients. 
Although ventricular arrhythmia is potentially harmful, they 
were all asymptomatic and did not require specific treatment. 
These were not different from those occurred in patients with 
COPD and OSA (1, 19, 20). 
  Interestingly and in contrast to the situation during the wak-
ing hours, there was significantly less hypoxemia during sleep 
in most patients. The two patients who experienced significant 
hypoxemia during sleep were hypoxemic more than 40% of 
waking hours. So, nocturnal hypoxemia seems to occur rarely, if 
any, in ILD patients without significant waking hour hypoxemia. 
Recently, Lancaster et al. reported that OSA is prevalent in pa-
tients with idiopathic pulmonary fibrosis (21). They reported 
88% of subjects had OSA. The gap between Lancaster’s report 
and ours may be due to the difference of body mass index (BMI). 
The mean BMI of our patients was 23.7 whereas, in Lancaster’s 
report, the mean BMI was 32.3. Their BMI was higher than those 
of our patients even in the patients with no OSA (BMI: 26). The 
ethnic difference can be another reason. 
  We can assume that resting arterial oxygenation is an impor-
tant predictor of nocturnal desaturation in patients with ILD. It 
is similar to COPD patients. Daytime arterial oxygen saturation 
is the most important predictor of nocturnal saturation in COPD 
patients, too (22). The sleep-related desaturation in COPD is a 
feature of advanced COPD patients with significant waking hour 
hypoxemia and hypercapnia, if they did not have overlap syn-
drome (23). And the coexistence of the COPD and sleep apnea 
is only due to chance (24). The importance of waking hour de-
saturation on nocturnal hypoxemia can be explained by the 
shape of the oxygen desaturation curve (23).
  There are several limitations in our study. First, the number 
of the subjects was small. However, to our knowledge, this is the 
Table 5. The relationship between six-minute walk test and duration of waking hour 
hypoxemia
Distance until  
80% of SpO2
Proportion of hypoxemia during  
waking hours Total P-value
≥ 10% < 10%
≥ 300 m 0   6   6 0.018
< 300 m 8   5 13
Total  8 11 19
6MWT, six-minute walk test; SpO2, pulse oximetric saturation. Park JH, et al.  •  Hypoxemia and Arrhythmia in Pulmonary Fibrosis
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first report that was performed by direct 24-hr Holter and pulse 
oximetry monitoring in patients with ILD and clearly demon-
strated high frequency of arrhythmias in the patients with ILD, 
although asymptomatic and need not be treated. Second, the 
oxygen saturation was monitored by pulse oximetry not by di-
rect arterial blood gas analysis. Although pulse oximetry is a clin-
ically valid alternative method of arterial blood gas analysis (25), 
its reliability and stability of signal cannot be guaranteed below 
80% of SpO2 (26, 27). However, because our aim is not measur-
ing the exact degree of hypoxemia, but estimating the duration 
of significant hypoxemia, pulse oximetry is adequate for our pur-
pose. Third, we could not control or evaluate the intensity of ac-
tivities. The oxygen desaturation depends on the degree of ac-
tivities as well as the severity of the disease. However, the aim of 
this study is to investigate the frequency of arrhythmia and the 
severity of hypoxemia during ordinary daily activities of ILD 
patients, not in controlled situation.
  In conclusion, the patients with ILD experienced significant 
hypoxemia during daily life and cardiac arrhythmia, mostly 
APCs and VPCs were frequently observed, which were not spe-
cifically correlated with hypoxemia. There were no clinically 
significant arrhythmia that required treatment despite the se-
vere desaturation during 6MWT and daily life, supporting the 
safety of 6MWT. Exercise induced hypoxemia during 6MWT, 
especially desaturation below 80% before 300 meters is a good 
surrogate marker for hypoxemia during daily life. Hypoxemia 
during sleep is not a problem in the patients with ILD without 
significant resting hypoxemia. 
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Hypoxemia and Arrhythmia during Daily Activities and Six-minute Walk Test in 
Fibrotic Interstitial Lung Diseases
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Most patients with fibrotic interstitial lung diseases (ILD) experience significant hypoxemia during exercise despite of normal 
saturation at rest. Cardiac arrhythmia frequently occurs in patients with other lung diseases which induce hypoxemia such as 
COPD. Therefore the patients with ILD may have serious cardiac arrhythmia especially during exercise. To evaluate the severity of 
hypoxemia and arrhythmia in fibrotic ILD, oxygen saturation and ECG were continuously monitored (24 hr). All 19 patients 
experienced significant hypoxemia in wake periods, whereas no significant hypoxemia was noted during sleep period except in the 
patients who already showed resting hypoxemia in daytime. Although arrhythmias were frequently observed (mostly atrial and 
ventricular premature contractions), they were asymptomatic and not specifically associated with hypoxemia. To evaluate the 
degree of hypoxemia in fibrotic ILD patients, 6-min walk test is commonly performed. Because the degree of hypoxemia during 
the 6-min walk would be similar with the ordinary daytime activity, the test seems to be safe.